However, reducing EZH2 levels has also been shown to have its dangers, as particular myelodysplastic syndromes naturally inactivate EZH2, suggesting a tumor suppressor role for EZH2 in this context [12–14]. Here, EZH2 is linked to myelodysplastic syndrome.